05:29 PM EDT, 05/22/2024 (MT Newswires) -- Michael J. Labarre, Senior Vice President, Chief Technical Officer, on May 21, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $905,480. Following the Form 4 filing with the SEC, Labarre has control over a total of 168,176 shares of the company, with 168,176 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924014123/xslF345X03/form4-05222024_090507.xml

Price: 45.00, Change: -0.48, Percent Change: -1.06